Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patients

AIDS Reviews

Volumn 12, Issue 3, 2010, Pages 153-163

  Imaz, Arkaitz ^a   Pujol, Miquel ^a   Barragán, Patricia ^a   Domínguez, María Ángeles ^a   Tiraboschi, Juan Manuel ^a   Podzamczer, Daniel ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Bacterial infections; Community acquired methicillin resistant Staphylococcus aureus; HIV; MRSA

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

BACTEREMIA; BACTERIAL COLONIZATION; CLINICAL FEATURE; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; DISEASE SEVERITY; DISEASE SURVEILLANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OUTCOME ASSESSMENT; PNEUMONIA; PREVALENCE; REVIEW; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; COMMUNICABLE DISEASE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCAL SKIN INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; HIV; HIV INFECTIONS; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 78049497815     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Zetola N, Francis J, Nuermberger E, Bishai W. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005;5:275-86. (Pubitemid 40602247)
2. Young D, Harris H, Charlebois E, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004;139:947-51.
3. Fridkin S, Hageman J, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44.
4. Naimi T, LeDell K, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-84. (Pubitemid 37505530)
5. Tenover F, McDougal L, Goering R, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol. 2006;44:108-18. (Pubitemid 43100588)
6. Vandenesch F, Naimi T, Enright M, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978-84. (Pubitemid 36944519)
7. Tenover F, Goering R. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology J Antimicrob Chemother. 2009;64:441-6.
8. McDougal L, Steward C, Killgore G, Chaitram J, McAllister S, Tenover F. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113-20. (Pubitemid 37429924)
9. David M, Daum R. Community-associated methicillin-resistant S aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616-87.
10. Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis. 2007;13:594-600.
11. Manzur A, Dominguez A, Pujol M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect. 2008;14:377-80.
12. Cercenado E, Cuevas O, Marin M, et al. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton-Valentine leukocidin-positive isolates. Diagn Microbiol Infect Dis. 2008;61:143-9.
13. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44:1549-55.
14. Rodriguez-Baño J, Dominguez M, Millán A, et al. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant S. aureus in Spain. Clin Microbiol Infect. 2009;15:1111-18.
15. Robinson D, Enright M. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003;47:3926-34.
16. Lina G, Piémont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-32. (Pubitemid 30265628)
17. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753-9. (Pubitemid 34215075)
18. Diep B, Palazzolo-Ballance A, Tattevin P, et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One. 2008;3e3198.
19. Huijsdens X, Van Santen-Verheuvel M, Spalburg E, et al. Multiple cases of familial transmission of community-acquired methicillin-resistant S. aureus. J Clin Microbiol. 2006;44:2994-6. (Pubitemid 44228603)
20. Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus infections in correctional facilities in Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep. 2003;52:992-6.
21. Baillargeon J, Kelley M, Leach C, Baillargeon G, Pollock B. Methicillin-resistant Staphylococcus aureus infection in the Texas prison system. Clin Infect Dis. 2004;38:e92-5.
22. Diep B, Chambers H, Graber C, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med. 2008;148:249-57.
23. Kazakova S, Hageman J, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468-75.
24. Ellis M, Hospenthal D, Dooley D, Gray P, Murray C. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971-9. (Pubitemid 39313452)
25. Campbell K, Vaughn A, Russell K, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol. 2004;42:4050-3.
26. Tong S, Bishop E, Lilliebridge R, et al. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis. 2009;199:1461-70.
27. Groom A, Wolsey D, Naimi T, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA. 2001;286:1201-5.
28. Atkinson S, Paul J, Sloan E, Curtis S, Miller R. The emergence of methicillin-resistant Staphylococcus aureus among injecting drug users. J Infect. 2009;58:339-45.
29. Charlebois E, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2004;39:47-54.
30. King M, Humphrey B, Wang Y, Kourbatova E, Ray S, Blumberg H. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft tissue infections. Ann Intern Med. 2006;144:309-17.
31. Moran G, Krishnadasan A, Gorwitz R, et al. Methicillin-resistant S.aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-74. (Pubitemid 44244537)
32. Onorato M, Borucki M, Baillargeon G, et al. Risk factors for colonization or infection due to methicillin-resistant Staphylococcus aureus in HIV-positive patients: a retrospective case-control study. Infect Control Hosp Epidemiol. 1999;20:26-30.
33. Senthilkumar A, Kumar S, Sheagren J. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis. 2001;33:1412-16. (Pubitemid 32955197)
34. Bär A, Hantschke D, Mirmohammadsadegh A, Hengge U. Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections: emergence of methicillin-resistant Staphylococci. AIDS. 2003;17:1253-6 (Pubitemid 36667768)
35. Skiest D, Brown K, Hester J, et al. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med. 2006;7:361-8.
36. Crum-Cianflone N, Burgi A, Hale B. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS. 2007;18:521-6.
37. Popovich K, Weinstein R, Aroutcheva A, Rice T, Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis. 2010;50:979-87.
38. Srinivasan A, Seifried S, Zhu L, et al. Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV. AIDS Res Hum Retroviruses 2009;25:1219-24.
39. Giuliani M, Longo B, Latini A, et al. No evidence of colonization with community-acquired methicillin-resistant Staphylococcus aureus in HIV-1-infected men who have sex with men. Epidemiol Infect. 2010;138:738-42.
40. Crum-Cianflone N, Grandits G, Echols S, et al. Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use. J Acquir Immune Defic Syndr. 2010;54:248-57.
41. Diep B, Chambers H, Graber C, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148 (19):249-57.
42. Sztramko R, Katz K, Antoniou T, et al. Community-associated methicillin-resistant Staphylococcus aureus infections in men who have sex with men: A case series. Can J Infect Dis Med Microbiol. 2007;18:257-61.
43. Hidron A, Kourbatova E, Halvosa J, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis. 2005;41:159-66.
44. Shastry L, Rahimian J, Lascher S. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York City. Arch Intern Med 2007;167:854-7.
45. Seybold U, Supthut-Schroder B, Draenert R, Hogardt M, Bogner J. Prevalence and risk factors of nasal colonization with Staphylococcus aureus - association with HIV infection in older patients. Scand J Infect Dis. 2009;41:63-6.
46. Szumowski J, Wener K, Gold H, et al. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clin Infect Dis. 2009;49:118-21.
47. Mathews W, Caperna J, Barber R, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr. 2005;40:155-60.
48. Lee N, Taylor M, Bancroft E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis. 2005;40:1529-34.
49. Madariaga M, Ullrich F, Swindells S. Low prevalence of community-acquired methicillin-resistant Staphylococcus aureus colonization and apparent lack of correlation with sexual behavior among HIV-infected patients in Nebraska. Clin Infect Dis. 2009;48:1485-7.
50. Miller M, Cespedes C, Vavagiakis P, Klein R, Lowy F. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis. 2003;22:463-9.
51. Huang H, Cohen S, King J, Monchaud C, Nguyen H, Flynn N. Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis. 2008;60:347-50.
52. Lloyd-Smith E, Hull M, Tyndall M, et al. Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. Epidemiol Infect. 2010;138:713-20.
53. Burkey M, Wilson L, Moore R, Lucas G, Francis J, Gebo K. The incidence of and risk factors for MRSA bacteremia in an HIV-infected cohort in the HAART era. HIV Med. 2008;9:858-62.
54. Ellis M, Gupta S, Galant S, et al. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis 1988;158:1268-76.
55. Flo R, Naess A, Nilsen A, Harthug S, Solberg C. A longitudinal study of phagocyte function in HIV-infected patients AIDS. 1994;8:771-7.
56. Pos O, Stevenhagen A, Meenhorst P, Kroon F, van Furth R. Impaired phagocytosis of Staphylococcus aureus by granulocytes and monocytes of AIDS patients. Clin Exp Immunol. 1992;88:23-8.
57. Dobmeyer T, Raffel B, Dobmeyer J, et al. Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur J Med Res. 1995;1:9-15.
58. Cenizal M, Hardy R, Anderson M, Katz K, Skiest D. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients. J Acquir Immune Defic Syndr. 2008;48:567-71.
59. Ramsetty S, Stuart L, Blake R, Parsons C, Salgado C. Risks for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection. HIV Med. 2010;11:389-94.
60. Shet A, Mathema B, Mediavilla J, et al. Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1. J Infect Dis. 2009;200:88-93.
61. Trinh T, Short W, Mermel L. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients. J Int Assoc Physicians AIDS Care (Chic III). 2009;8:176-80.
62. Wertheim H, Vos M, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364:703-5.
63. Gordon R, Lowy F. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46(Suppl 5):S350-9.
64. Nguyen M, Kauffman C, Goodman R, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999;130:221-5.
65. Weinke T, Schiller R, Fehrenbach F, et al. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1992;11:985-9.
66. Squier C, Rihs J, Risa K, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol. 2002;23:495-501.
67. Stevens A, Hennessy T, Baggett H, Bruden D, Parks D, Klejka J. Methicillin-resistant staphylococcus aureus carriage and risk factors for skin infections, Southwestern Alaska, USA. Emerg Infect Dis. 2010;16:797-803.
68. Cook H, Furuya E, Larson E, Vasquez G, Lowy F. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2007;44:410-13.
69. Miller M, Cook H, Furuya E, et al. Staphylococcus aureus in the community: colonization versus infection. PLoS One. 2009;4:e6708.
70. Yang E, Tan J, Eells S, Rieg G, Tagudar G, Miller L. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect. 2010;16:425-31.
71. Fowler A, Mackay A. Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user. J Med Microbiol. 2006;55:123-5.
72. Tseng C, Kyme P, Low J, et al. Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One. 2009;4:e6387.
73. Miller L, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445-53.
74. Bae I, Tonthat G, Stryjewski M, et al. Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol. 2009;47:3952-7.
75. Miller L, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis. 2007;44:483-92. (Pubitemid 46233248)
76. Francis J, Doherty M, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005;40:100-7. (Pubitemid 40053465)
77. Gillet Y, Etienne J, Lina G, Vandenesch F. Association of necrotizing pneumonia with Panton-Valentine leukocidin-producing Staphylococcus aureus, regardless of methicillin resistance. Clin Infect Dis. 2008;47:985-6.
78. Hidron A, Low C, Honig E, Blumberg H. Emergence of community-acquired methicillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis. 2009;9:384-92.
79. Robinson J, Pearson J, Christiansen K, Coombs G, Murray R. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis. 2009;28:353-61.
80. Millar B, Prendergast B, Moore J. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother. 2008;61:1-7.
81. Lee N, Kan C, Chi C, et al. Community-acquired methicillin-resistant Staphylococcus aureus mycotic aneurysm. Intern Med 2010;49:623-5.
82. Carrillo-Marquez M, Hulten K, Hammerman W, Mason E, Kaplan S. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J. 2009;28:1076-80.
83. Vander Have K, Karmazyn B, Verma M, et al. Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer. J Pediatr Orthop. 2009;29:927-31.
84. Gillet Y, Dohin B, Dumitrescu O, et al. [Osteoarticular infections with staphylococcus aureus secreting Panton-Valentine leucocidin]. Arch Pediatr. 2007;14(Suppl 2):S102-7.
85. Bruns A, Sood N. Community-acquired methicillin-resistant Staphylococcus aureus epidural abscess with bacteremia and multiple lung abscesses: case report. Am J Crit Care. 2009;88:86-7.
86. Naesens R, Ronsyn M, Druwé P, Denis O, Ieven M, Jeurissen A. Central nervous system invasion by community-acquired methicillin-resistant Staphylococcus aureus. J Med Microbiol. 2009;58:1247-51.
87. von Specht M, Gardella N, Tagliaferri P, Gutkind G, Mollerach M. Methicillin-resistant Staphylococcus aureus in community-acquired meningitis. Eur J Clin Microbiol Infect Dis. 2006;25:267-9.
88. Munckhof W, Krishnan A, Kruger P, Looke D. Cavernous sinus thrombosis and meningitis from community-acquired methicillin-resistant Staphylococcus aureus infection. Intern Med J 2008;38:283-7.
89. Adem P, Montgomery C, Husain A, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med. 2005;353:1245-51.
90. Tsai H, Chao P, Sy C, et al. Community-associated methicillin-resistant Staphylococcus aureus infective endocarditis with Panton-Valentine leukocidin gene in an injection drug user with HIV infection. Intern Med. 2008;47:1485-9.
91. Sayana S, Khanlou H. Meningitis due to hematogenous dissemination of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in a patient with AIDS. J Int Assoc Physicians AIDS Care (Chic III). 2008;7:289-91.
92. Crum-Cianflone N, Weekes J, Bavaro M. Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care STDS. 2009;23:499-502.
93. Graber C, Jacobson M, Perdreau-Remington F, Chambers H, Diep B. Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr. 2008;49:231-3.
94. Szumowski J, Cohen D, Kanaya F, Mayer K. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother. 2007;51:423-8.
95. Anderson E, Hawkins C, Bolon M, Palella F. A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41:125-7. (Pubitemid 41786032)
96. Cenizal M, Skiest D, Luber S, et al. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51:2628-30.
97. Ruhe J, Monson T, Bradsher R, Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis. 2005;40:1429-34.
98. Han L, McDougal L, Gorwitz R, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol. 2007;45:1350-2.
99. Lewis J, Jorgensen J. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis. 2005;40:280-5.
100. Stryjewski M, Chambers H. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Suppl 5):S368-77.
101. Le J, Lieberman J. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy. 2006;26:1758-70.
102. Ellis M, Lewis J. Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis. 2005;18:496-501.
103. Stryjewski M, Corey G. New treatments for methicillin-resistant Staphylococcus aureus. Curr Opin Crit Care. 2009;15:403-12.
104. Arbeit R, Maki D, Tally F, Campanaro E, Eisenstein B. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis. 2004;38:1673-81.
105. Fowler V, Boucher H, Corey G, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-65.
106. Silverman J, Mortin L, Vanpraagh A, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191:2149-52.
107. Stevens D, Herr D, Lampiris H, Hunt J, Batts D, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2002;34:1481-90.
108. Breedt J, Teras J, Gardovskis J, et al. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother. 2005;49:4658-66.
109. Stevens D, Ma Y, Salmi D, Mclndoo E, Wallace R, Bryant A. Impact of antibiotics on the expression of virulence-associated exotoxin genes in methicillin-sensitive and in methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195:202-11.
110. Dumitrescu O, Boisset S, Bes M, et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother. 2007;51:1515-19.
111. David M, Daum R. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616-87.
112. Gorwitz R, Jernigan D, Powers J, Jernigan J; Participants in the CDC Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006 Available at http://www.cdc.gov/ncidod/dhqp/ar-mrsa-ca.html.